HRS-1301

DRUG2 trials

Sponsors

Shandong Suncadia Medicine Co., Ltd.

Conditions

Hyperlipidemia

Phase 1

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1301 in Healthy Subjects

CompletedNCT06857253

Shandong Suncadia Medicine Co., Ltd.Hyperlipidemia

Start: 2025-03-18End: 2025-08-11Updated: 2025-12-19

Phase 2

A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia

RecruitingNCT07229937

Shandong Suncadia Medicine Co., Ltd.Hyperlipidemia

Start: 2025-11-25End: 2026-08-31Target: 189Updated: 2025-12-12